Surgery Partners (SGRY) Hisse Fiyat

Surgery Partners Fiyat

NASDAQ·KAPALI
14,85
​
Pazar kapalı

Gelir, son 14 yılda yıllık bileşik %23,2 artarak 3,31 Md USD seviyesine ulaştı. Hisse başına kâr, son 4 yılda yıllık %43,4 geriledi. Surgery Partners şirketinde net marj %-2,4 seviyesinde bulunuyor; birkaç yıl önceki %-3,2 seviyesine göre büyük ölçüde sabit kaldı. Analistler 18,50 USD medyan fiyat hedefi belirliyor; bu, güncel fiyatın %24,6 üzerinde bir seviyeye işaret ediyor. 18 analistten 14 tanesi hisse için alım öneriyor — genel konsensüs: Al.

Surgery Partners hisse senedi fiyatı

Bu verilere Eulerpool API üzerinden ulaşın

Ayda 100.000 ücretsiz istek · kredi kartı yok

Surgery Partners iş modeli ve hisse analizi

Surgery Partners Inc, ABD merkezli özel cerrahi hizmetlerde uzmanlaşmış bir şirkettir. 1997 yılında kurulmuş olup merkezi Tennessee eyaletinin Nashville şehrinde bulunmaktadır. Şirket, ayakta cerrahi müdahalelere odaklanarak göz cerrahisi, endoskopi, kulak-burun-boğaz (KBB) cerrahisi, jinekoloji, ortopedi, plastik cerrahi ve üroloji dahil olmak üzere çeşitli tıbbi hizmetler sunmaktadır. Surgery Partners, 32 eyalette 180'den fazla cerrahi merkez ve kliniğe sahiptir. Şirket, 2017 yılında Symbion Healthcare'ın satın alınmasıyla anestezi hizmetleri, ağrı yönetimi, tanı ve laboratuvar hizmetlerini de kapsayacak şekilde hizmet yelpazesini genişletmiştir. Ayrıca mükemmel hizmet kalitesine vurgu yapan şirket, cerrahi hizmetlerini yaymak amacıyla hastanelerle ortaklıklar kurmuştur.

Surgery Partners hakkında sık sorulan sorular

Surgery Partners Inc is primarily active in the healthcare industry. With a focus on providing surgical services, the company operates a network of outpatient surgical facilities, physician practices, and anesthesia services. By offering a comprehensive range of surgical solutions, Surgery Partners Inc aims to improve patient outcomes and enhance healthcare delivery. With its expertise in specialties such as orthopedics, gastroenterology, and ophthalmology, the company plays a crucial role in meeting the diverse healthcare needs of patients across different regions. Overall, Surgery Partners Inc's activities support the advancement and accessibility of quality healthcare services.

The business model of Surgery Partners Inc centers around providing a comprehensive range of surgical services through its network of ambulatory surgery centers, surgical hospitals, and contract services. With a focus on delivering high-quality, cost-effective care, Surgery Partners Inc aims to meet the needs of patients, physicians, and healthcare facilities. By offering a diverse range of surgical specialties, including orthopedics, gastroenterology, and ophthalmology, Surgery Partners Inc strives to improve patient outcomes and satisfaction. Through its strategic partnerships and operational expertise, the company continues to expand its footprint and strengthen its position within the healthcare industry.

The main competitors of Surgery Partners Inc in the market include Tenet Healthcare Corporation, HCA Healthcare, and UnitedHealth Group.

Surgery Partners Inc is a leading healthcare services company with an extensive history in the industry. Established in 2004, Surgery Partners has since grown to become a prominent player in providing surgical services across the United States. With a focus on delivering high-quality care in a cost-effective manner, the company operates a network of surgical facilities and ancillary services centers. Through strategic partnerships, Surgery Partners offers a range of surgical procedures in various specialties, ensuring access to a wide range of patients in need. With their commitment to exceptional patient care, Surgery Partners Inc has established itself as a trusted name in the healthcare sector.

Surgery Partners Inc has achieved several significant milestones in its history. One notable accomplishment includes the strategic acquisition of National Surgical Healthcare in 2017, which expanded the company's reach and capabilities in the outpatient surgical market. Additionally, Surgery Partners Inc achieved recognition as a leader in ambulatory surgery, providing high-quality healthcare services across multiple states. The company has also demonstrated consistent growth and financial performance, further establishing its position in the healthcare industry. Surgery Partners Inc continues to prioritize patient care and innovation, driving its success and reinforcing its reputation as an esteemed company in the stock market.

Surgery Partners Inc is primarily present in the United States.

Surgery Partners Inc values the highest standards of patient care, innovation, and excellence in healthcare services. With a patient-centric approach, the company strives to provide the most advanced surgical solutions and personalized care. The corporate philosophy revolves around compassionate healthcare delivery, continuous improvement, and ethical practices. Surgery Partners Inc is committed to fostering strong relationships with physicians, patients, and partners, while maintaining a focus on operational efficiency and financial strength. The company's dedication to quality outcomes, cutting-edge technology, and commitment to patient satisfaction embodies its core values and corporate philosophy.

Analistler şu anda Surgery Partners hissesi için ortalama 18,75 USD hedef fiyat belirliyor (medyan: 18,50 USD); bu, son fiyata göre +26,3 % anlamına gelir. Konsensüs 18 analist notuna dayanır.

18 analist şu anda Surgery Partners hissesini değerlendiriyor: 14 al, 4 tut, 0 sat öneriyor. 2026 için analistler Surgery Partners şirketinin 3,35 Md USD gelir ve 0,40 USD hisse başına kâr üretmesini bekliyor.

Güncel döviz kuruyla Surgery Partners hissesi 13,21 EUR (14,85 USD) seviyesindedir.

Surgery Partners hissesi (SGRY) 4 borsada işlem görür, bunlar arasında: NASDAQ (SGRY), Frankfurt (1SP.F), München (1SP.MU), Düsseldorf (1SP.DU).

Surgery Partners Inc. is a leading healthcare company that focuses on outpatient surgical centers and services for the healthcare industry. The company offers a variety of surgical and diagnostic services delivered on an outpatient basis. Surgery Partners Inc. operates over 180 facilities in 31 states in the USA and provides a wide range of surgical services. The business model of Surgery Partners Inc. is based on the goal of providing its patients with top-quality surgical services and continuous medical care at the highest level. The company has an extensive network of outpatient surgical centers and offers its patients a wide range of surgical and diagnostic services, including general surgery, orthopedics, ophthalmology, neurology, gastroenterology, gynecology, and many others. Surgery Partners Inc. also offers specialized procedures and services such as endoscopic examinations, imaging services, pain therapy, and rehabilitation. The company also operates an extensive diagnostic platform that includes advanced imaging technology and diagnostic procedures such as endoscopy and biopsy. The company also has a focus on the development and utilization of cutting-edge technology in surgery and diagnostics to ensure that patients receive excellent medical care. Surgery Partners Inc. also maintains extensive partnerships with healthcare providers and hospitals to enable better coordinated care. The company collaborates with numerous facilities to meet the needs of patients and provide them with a seamless healthcare experience. These partnerships allow Surgery Partners Inc. to expand its network of facilities and improve its services. Surgery Partners Inc. is also actively involved in research and development, working to develop new procedures and technologies to improve surgical services. The company has a strong team of researchers and physicians who continuously seek new opportunities to enhance surgery and diagnostics, thereby ensuring better healthcare. Overall, the business model of Surgery Partners Inc. is focused on providing top-quality surgical and diagnostic services on an outpatient basis. The company operates an extensive network of surgical facilities and offers a wide range of surgical and diagnostic services to meet the needs of its patients. Through healthcare partnerships and the use of cutting-edge technologies, Surgery Partners Inc. strives to provide better healthcare for its patients.

beklenen'nin Surgery Partners hasılatı 3,35 Md USD'dir. Bu rakam, mevcut finansal verilere dayanmakta ve şirketin iş performansını yansıtmaktadır.

beklenen'nin Surgery Partners karı 51,10 M USD'dir. Net kar, tüm giderleri düştükten sonra şirketin kârlılığını gösterir.

Surgery Partners'nin Fiyat/Kazanç (F/K) oranı şu anda 36,95'dir. F/K oranı, cari hisse fiyatını hisse başına kazançla karşılaştırır ve yatırımcıların Surgery Partners hisse senedinin değerlemesini değerlendirmelerine yardımcı olur.

Surgery Partners'nin Fiyat/Satış (F/S) oranı şu anda 0,56'dir. F/S oranı, pazar kapitalizasyonunu yıllık gelirle karşılaştırır ve Surgery Partners hisse senedinin değerleme metriği olarak hizmet eder.

Surgery Partners'nin Eulerpool Kalite Puanı 3/10'dur.

Surgery Partners'nin ISIN'i US86881A1007'dir. ISIN (Uluslararası Menkul Kıymetler Kimlik Numarası), menkul kıymetler için küresel olarak benzersiz bir tanımlayıcıdır.

Surgery Partners'nin WKN'i A14YWP'dir. WKN (Wertpapierkennnummer), menkul kıymetleri tanımlamak için kullanılan altı haneli bir Alman kimlik numarasıdır.

Surgery Partners'nin ticker'ı SGRY'dir. Ticker sembolü, Surgery Partners hisseleri borsada işlem görmek için kullanılır.

Adil DeğerTerminal
12,77 USD
Aşırı-/Eksik DeğerlemeTerminal
Adil Değerlenmiş
Sektor
Sektör
Sağlık Hizmetleri Sağlayıcıları & Hizmetleri
Hisse Sayısı
Çalışan Sayısı
Çalışan Başına Ciro
206.793,75 USD
Gelir Büyümesi Ø5 Yıl
EBIT Büyümesi Ø5 Yıl
Net Kar Büyümesi Ø5 Yıl
Para Birimi
USD
Halka Arz
1 Eki 2015
ISIN
US86881A1007
CUSIP
86881A100
SEDOL
BYTC1B2
Pazar Kapitalizasyonu
1,87 Md USDSmall Cap
52 Haftalık Aralık
AAQS
3 / 10
PEG
-2,88
F/K Oranı 2026
36,64
F/K Oranı 2027
34,42
F/K Oranı 2028
24,82
F/K Oranı 2029
26,51
P/S
F/S Oranı
0,56
EV/EBIT
13,81
KBV
1,09
ROIC
-1,43 %
Son güncelleme 18 Eki 2026 23:14

Surgery Partners Ticker

DÜSSELDORF · 1SP.DUFRANKFURT · 1SP.FMÜNIH · 1SP.MUNASDAQ · SGRY

Surgery Partners FIGI

SGRY:US · BBG009T0TKV8SGRY:UA · BBG009T0TLN5SGRY:UC · BBG009T0TLP3SGRY:UN · BBG009T0TLR1SGRY:UP · BBG009T0TLS0SGRY:UB · BBG009T0TLV6SGRY:UM · BBG009T0TLX4SGRY:UX · BBG009T0TLY3SGRY:UD · BBG009T0TM35SGRY:UW · BBG009T0TM53SGRY:UF · BBG009T0TM62SGRY:VY · BBG009T0TM71

Surgery Partners'nin tüm temel göstergeleri ve derinlemesine analizi

Surgery Partners hissesine yönelik aktienanalizimiz, satış, kar, P/E oranı, P/S oranı, EBIT gibi önemli mali kriterleri içermekte olup, dividende bilgilerini de ele almaktadır. Ayrıca, hisseler, piyasa değeri, borçlar, özsermaye ve Surgery Partners şirketin yükümlülükleri gibi konuları incelemekteyiz. Bu konular hakkında daha detaylı bilgilere ihtiyacınız varsa, web sitemizin alt sayfalarında kapsamlı analizler sunuyoruz: